In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Patpol supports a World IP Day’s event organized by the Polish Patent Office

Many women in Poland live with breast cancer without even being aware of it, and Czytaj dalej

Patpol and its patent and trademark attorneys recommended in the latest IP Stars 2020 rankings

In the latest IP Stars 2020 ranking recognizing the best IP law firms in terms Czytaj dalej

PATPOL IP RUNNERS once again at the start and finish line of POLAND BUSINESS RUN!

A Patpol and Patpol Legal running team composed of: Aleksandra Sołyga-Żurek, Anna Wiśniewska, Dariusz Piróg, Czytaj dalej